益气温阳通窍平喘方联合常规西药治疗过敏性鼻炎-哮喘综合征临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R725.6;R765.21

基金项目:


Clinical Study on Yiqi Wenyang and Tongqiao Pingchuan Prescriptions Combined with Routine Western Medicine for Combined Allergic Rhinitis and Asthma Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察益气温阳通窍平喘方联合常规西药治疗过敏性鼻炎-哮喘综合征的临床疗效。方法:选 择104 例过敏性鼻炎-哮喘综合征患者为研究对象,按随机数字表法分为观察组和对照组各52 例。对照组采用 西医对症治疗,观察组在对照组基础上加用益气温阳通窍平喘方治疗。比较2 组临床疗效、中医证候评分、气 道炎症因子水平和不良反应发生情况。结果:观察组总有效率为94.2%,高于对照组73.1%,差异有统计学意 义(P<0.05)。治疗后,2 组喘息咳痰、咳嗽气促、神疲乏力、鼻塞、喷嚏及流清涕评分低于治疗前(P< 0.05), 且观察组各项评分低于对照组(P<0.05)。治疗后, 2 组白细胞介素-2 (IL-2)、干扰素- γ(IFN-γ) 水平较治疗前升高,白细胞介素-4(IL-4)、白细胞介素-6(IL-6) 及C-反应蛋白(CRP) 水平较 治疗前降低(P<0.05);且观察组IL-2、IFN-γ 水平高于对照组,IL-4、IL-6 及CRP 水平低于对照组(P< 0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:益气温阳通窍平喘方联合常规西药治 疗过敏性鼻炎-哮喘综合征的效果较好,有助于改善患者临床症状,缓解气道炎症,且安全性较高。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Yiqi Wenyang and Tongqiao Pingchuan Prescription combined with routine western medicine for combined allergic rhinitis and asthma syndrome. Methods: A total of 104 cases of patients with combined allergic rhinitis and asthma syndrome were selected as the study objects and divided into the observation group and the control group,with 52 cases in each group. The control group was treated with symptomatic treatment of western medicine, and the observation group was additionally treated with Yiqi Wenyang and Tongqiao Pingchuan Prescriptions based on the treatment of the control group. Clinical effects,traditional Chinese medicine syndrome scores,the levels of airway inflammatory factors and the incidence of adverse reactions were compared between the two groups. Results: The total effective rate was 94.2% in the observation group, higher than that of 73.1% in the control group, the difference being significant (P<0.05). After treatment, the scores of dyspnea and expectoration, cough and shortness of breath, fatigue and lack of strength, nasal congestion, sneeze, and clear nasal discharge in the two groups were decreased when compared with those before treatment (P<0.05),and the above scores in the observation group were lower than those in the control group (P<0.05). After treatment,the levels of interleukin-2 (IL-2) and interferon-γ (IFN-γ) in the two groups were increased when compared with those before treatment,and the levels of interleukin- 4 (IL- 4), interleukin- 6 (IL- 6) and C- reactive protein (CRP) in the two groups were decreased when compared with those before treatment (P<0.05);the levels of IL- 2 and IFN- γ in the observation group were higher than those in the control group,and the levels of IL-4,IL-6 and CRP in the observation group were lower than those in the control group (P<0.05). There was no significant difference being found in the comparison of the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Yiqi Wenyang and Tongqiao Pingchuan Prescriptions combined with routine western medicine has a good effect in treating combined allergic rhinitis and asthma syndrome,and can conduce to the improvement of clinical symptoms and the remission of airway inflammation,with high safety.

    参考文献
    相似文献
    引证文献
引用本文

蔡青,张镭.益气温阳通窍平喘方联合常规西药治疗过敏性鼻炎-哮喘综合征临床研究[J].新中医,2023,55(5):159-162

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-03-15
  • 出版日期: